(Q37951776)

25 August 2017

title

Screening for colorectal cancer: established and emerging modalities (English)

1 reference

25 August 2017

1 reference

1 reference

Nikhil Pawa

1

1 reference

25 August 2017

Tan Arulampalam

series ordinal

2

1 reference

25 August 2017

John D Norton

series ordinal

3

1 reference

25 August 2017

language of work or name

English

0 references

publication date

1 November 2011

1 reference

Nature Reviews Gastroenterology & Hepatology

25 August 2017

published in

1 reference

25 August 2017

volume

8

1 reference

25 August 2017

issue

12

1 reference

25 August 2017

page(s)

711-722

1 reference

https://scigraph.springernature.com/pub.10.1038/nrgastro.2011.205

25 August 2017

exact match

0 references

cites work

Noninvasive molecular biomarkers for the detection of colorectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Early detection of colon cancer: new tests on the horizon

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Colorectal cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Molecular detection of colorectal neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Progress and challenges in colorectal cancer screening and surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Effect of screening colonoscopy on colorectal cancer incidence and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Association between colonoscopy rates and colorectal cancer mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Association of colonoscopy and death from colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Protection from right- and left-sided colorectal neoplasms after colonoscopy: population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Rates of new or missed colorectal cancer after barium enema and their risk factors: a population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

CT colonography of colorectal polyps: a metaanalysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Meta-analysis comparing CT colonography, air contrast barium enema, and colonoscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Advances in colorectal cancer screening.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Cost-effectiveness of computed tomographic colonography screening for colorectal cancer in the medicare population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Once-Only Sigmoidoscopy in Colorectal Cancer Screening: Follow-up Findings of the Italian Randomized Controlled Trial--SCORE

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Option appraisal of population-based colorectal cancer screening programmes in England

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, hemoccult

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Colorectal cancer screening in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Colorectal cancer screening in Europe: differences in approach; similar barriers to overcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Performance characteristics and evaluation of an automated-developed and quantitative, immunochemical, fecal occult blood screening test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Comparison of a guaiac based and an immunochemical faecal occult blood test in screening for colorectal cancer in a general average risk population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

As tests evolve and costs of cancer care rise: reappraising stool-based screening for colorectal neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Stool DNA and occult blood testing for screen detection of colorectal neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

DNA methylation-based fecal biomarkers for the noninvasive screening of GI cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Fecal DNA testing compared with conventional colorectal cancer screening methods: a decision analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Circulating tumor cells (CTC) detection: clinical impact and future directions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Circulating tumour cell detection on its way to routine diagnostic implementation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Detection, clinical relevance and specific biological properties of disseminating tumour cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Circulating tumor cells in colorectal cancer: correlation with clinical and pathological variables

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Clinical significance of cytokeratin 20-positive circulating tumor cells detected by a refined immunomagnetic enrichment assay in colorectal cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Circulating tumor cells in colorectal cancer: past, present, and future challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Circulating Tumor Cells and Colorectal Cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Circulating tumour cells early predict progression-free and overall survival in advanced colorectal cancer patients treated with chemotherapy and targeted agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Heterogeneous detection of circulating tumor cells in patients with colorectal cancer by immunomagnetic enrichment using different EpCAM-specific antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

A rare-cell detector for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Reliable and sensitive identification of occult tumor cells using the improved rare event imaging system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Isolation of rare circulating tumour cells in cancer patients by microchip technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Isolation and characterization of circulating tumor cells from patients with localized and metastatic prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Recent advances in the molecular diagnosis and prognosis of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

21 January 2018

Carcinoembryonic antigen

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Blood markers for early detection of colorectal cancer: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Identification of biomarkers for colorectal cancer through proteomics-based approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

The use of a colon cancer associated nuclear antigen CCSA-2 for the blood based detection of colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Elevated serum matrix metalloproteinase 9 (MMP-9) concentration predicts the presence of colorectal neoplasia in symptomatic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Identification of S100A8 and S100A9 as serological markers for colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Identification of cancer autoantigens in serum: toward diagnostic/prognostic testing?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Identification of lung cancer with high sensitivity and specificity by blood testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Seromic profiling of ovarian and pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Identification of tumor-associated autoantigens for the diagnosis of colorectal cancer in serum using high density protein microarrays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Identification of MST1/STK4 and SULF1 proteins as autoantibody targets for the diagnosis of colorectal cancer by using phage microarrays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Challenges for biomarker discovery in body fluids using SELDI-TOF-MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Use of proteomic patterns in serum to identify ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Possible detection of pancreatic cancer by plasma protein profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Genomic and oncoproteomic advances in detection and treatment of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Proteomic serum biomarkers and their potential application in cancer screening programs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Identification of serum proteins discriminating colorectal cancer patients and healthy controls using surface-enhanced laser desorption ionisation-time of flight mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Limitations in SELDI-TOF MS whole serum proteomic profiling with IMAC surface to specifically detect colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Detection of colorectal cancer using MALDI-TOF serum protein profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Proteomic profiling of urine for the detection of colon cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Combination of SELDI-TOF-MS and data mining provides early-stage response prediction for rectal tumors undergoing multimodal neoadjuvant therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Analysis of post-operative changes in serum protein expression profiles from colorectal cancer patients by MALDI-TOF mass spectrometry: a pilot methodological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

The blood peptidome: a higher dimension of information content for cancer biomarker discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Reproducibility in protein profiling by MALDI-TOF mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Analytical and preanalytical biases in serum proteomic pattern analysis for breast cancer diagnosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

7(th) HUPO World Congress of Proteomics: launching the second phase of the HUPOPlasma Proteome Project (PPP-2) 16-20 August 2008, Amsterdam, The Netherlands.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Absolute abundance for the masses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

A targeted proteomics-based pipeline for verification of biomarkers in plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Integrated barcode chips for rapid, multiplexed analysis of proteins in microliter quantities of blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Matrix-insensitive protein assays push the limits of biosensors in medicine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Circulating nucleic acids as a potential source for cancer biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Cell-free nucleic acids as biomarkers in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Circulating mutant DNA to assess tumor dynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Development of personalized tumor biomarkers using massively parallel sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Heteroplasmic mitochondrial DNA mutations in normal and tumour cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Analysis of circulating tumor DNA to confirm somatic KRAS mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

DNA methylation biomarkers for blood-based colorectal cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Circulating methylated SEPT9 DNA in plasma is a biomarker for colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Performance of epigenetic markers SEPT9 and ALX4 in plasma for detection of colorectal precancerous lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Novel blood-based, five-gene biomarker set for the detection of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

A case-controlled validation study of a blood-based seven-gene biomarker panel for colorectal cancer in Malaysia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Impact of miRNAs in gastrointestinal cancer diagnosis and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

MicroRNA dysregulation in colorectal cancer: a clinical perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

MicroRNAs are novel biomarkers of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Circulating microRNAs in plasma of patients with gastric cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Fecal MicroRNAs as novel biomarkers for colon cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Cancer biomarkers: can we turn recent failures into success?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Emerging molecular biomarkers--blood-based strategies to detect and monitor cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Screening for colorectal cancer in adults at average risk: a summary of the evidence for the U.S. Preventive Services Task Force

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

A quantitative immunochemical fecal occult blood test for colorectal neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Cytokeratins and carcinoembryonic antigen in diagnosis, staging and prognosis of colorectal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Estimating the probability of cancer with several tumor markers in patients with colorectal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Fecal multiple molecular tests to detect colorectal cancer in stool.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Improved fecal DNA test for colorectal cancer screening.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Artificial neural networks analysis of surface-enhanced laser desorption/ionization mass spectra of serum protein pattern distinguishes colorectal cancer from healthy population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

An integrated approach to the detection of colorectal cancer utilizing proteomics and bioinformatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Identification of serum biomarkers for colon cancer by proteomic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Biomarker discovery in MALDI-TOF serum protein profiles using discrete wavelet transformation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Sensitive detection of colorectal cancer in peripheral blood by septin 9 DNA methylation assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Quantitative detection of promoter hypermethylation in multiple genes in the serum of patients with colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Initial analyses of colon cancer-specific antigen (CCSA)-3 and CCSA-4 as colorectal cancer-associated serum markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Diagnostic accuracy of immunochemical versus guaiac faecal occult blood tests for colorectal cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Influence of seasonal variations in ambient temperatures on performance of immunochemical faecal occult blood test for colorectal cancer screening: observational study from the Florence district

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Colonoscopy in colorectal-cancer screening for detection of advanced neoplasia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Colorectal cancer screening

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

How much does colonoscopy reduce colon cancer mortality?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Fast track referrals for colorectal cancer: the impact of the faecal occult blood test screening programme

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Cost-effectiveness of double-contrast barium enema in screening for colorectal cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

The impact of CT colonography for colorectal cancer screening on the UK NHS: costs, healthcare resources and health outcomes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

New immunochemical fecal occult blood test with two-consecutive stool sample testing is a cost-effective approach for colon cancer screening: results of a prospective multicenter study in Chinese patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Practical advances in stool screening for colorectal cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

A simplified, noninvasive stool DNA test for colorectal cancer detection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Cytomorphology of circulating colorectal tumor cells:a small case series.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Preoperative carcinoembryonic antigen level as a prognostic indicator in colorectal cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Prognostic and diagnostic value of spontaneous tumor-related antibodies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

The peripheral blood transcriptome dynamically reflects system wide biology: a potential diagnostic tool

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Diagnostic applications of cell-free and circulating tumor cell-associated miRNAs in cancer patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Screening for colorectal cancer in Chinese: comparison of fecal occult blood test, flexible sigmoidoscopy, and colonoscopy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.205

Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer

31 March 2020

1 reference

12 December 2020

Classification and diagnostic prediction of colorectal cancer using protein profiling of serum and bioinformatics

1 reference

12 December 2020

Circulating nucleic acids (CNAs) and cancer--a survey

1 reference

12 December 2020

Cluster randomization trial of sequence mass screening for colorectal cancer

1 reference

12 December 2020

Development and evaluation of a colorimetric membrane-array method for the detection of circulating tumor cells in the peripheral blood of Taiwanese patients with colorectal cancer.

1 reference

12 December 2020

Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men.

1 reference

12 December 2020

The use of serologic tumor markers in gastrointestinal malignancies

1 reference

12 December 2020

A blood-based biomarker panel for stratifying current risk for colorectal cancer.

1 reference

12 December 2020

Molecular detection of APC, K- ras, and p53 mutations in the serum of colorectal cancer patients as circulating biomarkers.

1 reference

12 December 2020

Diagnosis and monitoring of colorectal cancer by L6 blood serum polymerase chain reaction is superior to carcinoembryonic antigen-enzyme-linked immunosorbent assay

1 reference

12 December 2020

10.1038/NRGASTRO.2011.205

Identifiers

DOI

1 reference

Dimensions Publication ID

25 August 2017

1005270010

0 references

Fatcat ID

release_qgswlrrge5dilffyvuqqdbkg4y

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/qgswlrrge5dilffyvuqqdbkg4y

24 November 2022

mapped directly with Wikidata item

1 reference